We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$22.8B
AUM Growth
-$510M
Cap. Flow
-$2.26B
Cap. Flow %
-9.9%
Top 10 Hldgs %
40.08%
Holding
187
New
21
Increased
43
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$207M
2
ANSS
Ansys
ANSS
+$201M
3
WWD icon
Woodward
WWD
+$192M
4
SWN
Southwestern Energy Company
SWN
+$168M
5
SQSP
Squarespace, Inc.
SQSP
+$130M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$294M
2
NDAQ icon
Nasdaq
NDAQ
+$256M
3
CRM icon
Salesforce
CRM
+$231M
4
AZN icon
AstraZeneca
AZN
+$188M
5
ARMK icon
Aramark
ARMK
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 31.84%
2 Technology 13.48%
3 Financials 9.84%
4 Communication Services 6.79%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
51
Tenet Healthcare
THC
$22.6B
$115M 0.5%
692,442
+5,000
+0.7% +$756K
LBPH
52
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$105M 0.46%
3,150,857
+210,357
+7% +$7.24M
DFS
53
DELISTED
Discover Financial Services
DFS
$102M 0.45%
725,000
+565,000
+353% +$76M
BEKE icon
54
KE Holdings
BEKE
$19.6B
$94.4M 0.41%
4,740,833
– –
X
55
DELISTED
US Steel
X
$85M 0.37%
2,405,000
+695,000
+41% +$26.5M
ICLR icon
56
Icon
ICLR
$13.3B
$63.4M 0.28%
220,800
+42,600
+24% +$13.4M
CRNX icon
57
Crinetics Pharmaceuticals
CRNX
$8.99B
$59.4M 0.26%
1,162,000
+665,000
+134% +$34.3M
CHX
58
DELISTED
ChampionX
CHX
$58.9M 0.26%
1,955,000
+1,170,000
+149% +$37M
COR icon
59
Cencora
COR
$60.7B
$52.9M 0.23%
235,200
-7,600
-3% -$1.76M
IBIT icon
60
iShares Bitcoin Trust
IBIT
$57.7B
$52M 0.23%
+1,440,000
New +$50M
LBRDK
61
DELISTED
Liberty Broadband Class C
LBRDK
$51M 0.22%
+660,000
New +$40.8M
JNPR
62
DELISTED
Juniper Networks
JNPR
$50.1M 0.22%
+1,285,000
New +$49M
HR icon
63
Healthcare Realty
HR
$6.65B
$47.2M 0.21%
+2,603,000
New +$46.1M
CNC icon
64
Centene
CNC
$32.1B
$46.3M 0.2%
614,917
-1,553,258
-72% -$114M
EDR
65
DELISTED
Endeavor Group Holdings, Inc.
EDR
$45.8M 0.2%
+1,605,000
New +$44.1M
CNTA
66
DELISTED
Centessa Pharmaceuticals
CNTA
$45M 0.2%
2,814,318
+818,318
+41% +$10M
BBIO icon
67
BridgeBio Pharma
BBIO
$15.9B
$44.5M 0.2%
+1,747,000
New +$45.9M
AXNX
68
DELISTED
Axonics, Inc. Common Stock
AXNX
$36M 0.16%
517,000
+147,000
+40% +$10.1M
LQDA icon
69
Liquidia Corp
LQDA
$6.14B
$32.9M 0.14%
3,290,956
+1,235,956
+60% +$13.5M
GDS icon
70
GDS Holdings
GDS
$6.58B
$31.2M 0.14%
1,531,133
+305,000
+25% +$4.31M
SIMO icon
71
Silicon Motion
SIMO
$8.76B
$31.2M 0.14%
514,000
-53,534
-9% -$3.53M
ENTA icon
72
Enanta Pharmaceuticals
ENTA
$392M
$21.8M 0.1%
2,108,262
+13,262
+0.6% +$173K
MTTR
73
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$19.6M 0.09%
+4,355,096
New +$19M
SVRA icon
74
Savara
SVRA
$1.15B
$19.3M 0.08%
4,560,000
– –
EVH icon
75
Evolent Health
EVH
$536M
$18.1M 0.08%
+639,000
New +$16.5M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2024 Portfolio in Review

As of Q3 2024, Thomas Steyer held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Thomas Steyer withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Woodward worth $198M.

  • Thomas Steyer's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
  • Thomas Steyer added most to Walt Disney in Q3 2024, an estimated $207M increase.
  • Thomas Steyer's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
  • Thomas Steyer fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
  • Thomas Steyer's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
  • Thomas Steyer opened 21 new positions and closed 22 in Q3 2024.
  • Thomas Steyer's portfolio value fell 2.2% quarter-over-quarter to $22.8B.

Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.